Warfarin dosing guided by genotype feasible in practice
Dosing algorithms for warfarin that account for patients’ genotype are feasible and can accurately predict dose requirements but their clinical utility is yet to be proven, according to a trial presented at the recent American Heart Association meeting in Orlando....
Want to read complete article? Please Sign in or Register.